首页> 美国卫生研究院文献>other >A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients

【2h】

A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients

机译：塞来昔布联合化疗对转移性或术后复发性胃癌患者的临床疗效和安全性的综合评估

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim:To evaluate the efficacy and safety of celecoxib combined with chemotherapy in the treatment of metastatic or postoperative recurrent gastric cancer.

机译：目的：评价塞来昔布联合化学疗法治疗转移性或术后复发性胃癌的疗效和安全性。

著录项

期刊名称 other
作者
Qinghong Guo; Qiang Li; Jiong Wang; Min Liu; Yuping Wang; Zhaofeng Chen; Yuwei Ye; Quanlin Guan; Yongning Zhou;
展开▼
作者单位

展开▼
年(卷),期 -1(98),27
年度 -1
页码 e16234
总页数 10
原文格式 PDF
正文语种
中图分类
关键词
celecoxib chemotherapy gastric cancer overall survival progression-free survival;

机译：塞来昔布;化学疗法;胃癌;总生存期;无进展生存期;

相似文献

外文文献
中文文献
专利

1. 53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin?) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva?) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer [J] . R.Herbst, V.ONeill, L.Fehrenbacher, European Journal of Cancer Supplements . 2006,第12期

机译：53 POSTER A II期，多中心，随机临床试验，评估贝伐单抗（Avastin？）联合化疗（多西他赛或培美曲塞）或盐酸厄洛替尼（Tarceva？）与单纯化疗联合治疗复发或难治性的疗效和安全性非小细胞肺癌
2. Safety, pharmacokinetic, and clinical activity profiles of ramucirumab in combination with three platinum/fluoropyrimidine doublets in Japanese patients with chemotherapy-naive metastatic gastric/gastroesophageal junction cancer [J] . Shitara Kohei, Kadowaki Shigenori, Nishina Tomohiro, Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association . 2018,第1期

机译：Ramucirumab的安全性，药代动力学和临床活性谱与日本化疗 - 幼稚转移性胃/胃食管癌癌症患者的三个铂/氟嘧啶双峰组合
3. A randomised phase II study to evaluate the efficacy and safety of chemotherapy (CT) vs Androgen Deprivation Therapy (ADT) in patients with recurrent and/or metastatic, Androgen Receptor (AR) expressing, Salivary Gland Cancer (SGC) [J] . Caballero C., Locati L., Urbanowicz M., Virchows Archiv: an international journal of pathology . 2017,第Suppla1期

机译：一种随机期II研究，评估复发性和/或转移，雄激素受体（AR）表达，唾液腺癌（SGC）患者患者化疗（CT）对雄激素剥夺治疗（ADT）的疗效和安全性
4. Improving Efficacy of Metastatic Tumor Segmentation to Facilitate Early Prediction of Ovarian Cancer Patients' Response to Chemotherapy [C] . Gopichandh Danala, Yunzhi Wang, Theresa Thai, Biophotonics and immune responses XII . 2017

机译：提高转移性肿瘤分割的功效，以促进卵巢癌患者对化疗的反应的早期预测
5. Treatment Patterns and Cost-Effectiveness of Chemotherapy Treatments among Advanced Gastric Cancer Patients [D] . Haag, Austin Jade. 2017

机译：晚期胃癌患者化学疗法的治疗模式和成本效益
6. Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer [O] . Qinghong Guo, Xiaojun Liu, Linzhi Lu, -1

机译：塞来昔布联合化疗治疗胃癌的临床疗效和安全性的综合评价
7. Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer [O] . Qinghong Guo, Xiaojun Liu, Linzhi Lu, 2017

机译：伴随化疗胃癌临床疗效和安全性综合评价

A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients

摘要

著录项

相似文献

相关主题

期刊订阅